Latest filing published 18 Nov 2015 for Innophos Holdings, Inc., €53k.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Mark Thurston: trading record in brief
Mark Thurston discloses dealings in Innophos Holdings, Inc. to SEC (Form 4). In total, 44 filings cover trades dated from 7 November 2006 to 16 November 2015.
In open-market terms, that means 1 purchase worth €1,878 on one side and 13 sales worth €4.4M on the other. Sales outweigh purchases by €4.4M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 17 share grants and 13 option exercises.
The newest entry dates from 18 November 2015: an option exercise of €53k, in Innophos Holdings, Inc. The last insider purchase was made public on 6 November 2006, 7,307 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Mark Thurston
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 3,100 shares@ US$18.38Common StockSEC:0001127602-15-031828:0
- 987 shares@ US$49.54Common StockSEC:0001127602-15-017003:0
- 299 shares@ US$57.49Common StockSEC:0001127602-15-013172:0
- 159 shares@ US$55.98Common StockSEC:0001127602-14-019668:0
- 1,966 shares@ US$57.27Common StockSEC:0001127602-14-015793:0
- 1,966 shares@ US$18.38Common StockSEC:0001127602-14-015793:1
- 194 shares@ US$55.98Common StockSEC:0001127602-14-015033:0
- 1,034 shares@ US$18.38Common StockSEC:0001127602-14-013951:0
- 1,034 shares@ US$57.10Common StockSEC:0001127602-14-013488:2
- 196 shares@ US$55.98Common StockSEC:0001127602-14-013120:1
- 1,034 shares@ US$57.10Common StockSEC:0001127602-14-013120:2
- 6,100 shares@ US$15.20Common StockSEC:0001127602-13-029555:0
- 2,400 shares@ US$18.38Common StockSEC:0001127602-13-029555:1
- 8,500 shares@ US$55.02Common StockSEC:0001127602-13-029555:2
- 6,900 shares@ US$15.20Common StockSEC:0001127602-13-028775:0
- 10,000 shares@ US$14.57Common StockSEC:0001127602-13-028775:1
- 20,000 shares@ US$53.09Common StockSEC:0001127602-13-028775:2
- 22,736 shares@ US$51.12Common StockSEC:0001127602-13-025536:0
- 953 shares@ US$54.59Common StockSEC:0001127602-13-012837:0
- 54 shares@ US$54.59Common StockSEC:0001127602-13-012837:1
- 1,803 shares@ US$52.49Common StockSEC:0001127602-13-010453:1
- 502 shares@ US$50.12Common StockSEC:0001127602-12-012891:0
- 8,000 shares@ US$50.38Common StockSEC:0001127602-12-009255:0
- 2,475 shares@ US$50.38Common StockSEC:0001127602-12-009255:1
- 9,800 shares@ US$42.50Common StockSEC:0001127602-11-008742:0
25 of 37 declarations